1. Inicio
  2. Proyectos y Estudios
  3. An Open-Label, Multicenter, Extension Trial to Evaluate the Long-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab.

An Open-Label, Multicenter, Extension Trial to Evaluate the Long-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab.

Datos básicos

ENSAYO CLÍNICO SRK-015-004 2022-001771-14 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2023

Objetivos del proyecto

Objetivo Principal: Evaluate the long-term safety and tolerability of apitegromab in patients with Type 2 and Type 3 SMA Objetivos Secundarios: Evaluate the long-term efficacy of apitegromab by assessing changes in motor function outcome measures at prespecified time points Further evaluate the immunogenicity of apitegromab

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

SCHOLAR ROCK, INC.

Compartir